SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001140361-20-011682
Filing Date
2020-05-15
Accepted
2020-05-14 21:57:37
Documents
6
Effectiveness Date
2020-05-15

Document Format Files

Seq Description Document Type Size
1 POSASR nt10011952x1_posasr.htm POSASR 599927
2 EXHIBIT 5.1 nt10011952x1_ex5-1.htm EX-5.1 13146
3 EXHIBIT 5.2 nt10011952x1_ex5-2.htm EX-5.2 24449
4 EXHIBIT 23.1 nt10011952x1_ex23-1.htm EX-23.1 4283
5 logo_cooley.jpg GRAPHIC 19237
6 logo_myovantsciences.jpg GRAPHIC 50637
  Complete submission text file 0001140361-20-011682.txt   738776
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: POSASR | Act: 33 | File No.: 333-231764 | Film No.: 20880274
SIC: 2834 Pharmaceutical Preparations